Cardiac glycosides: prerequisites for the development of new cardiotonic compounds.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001681:Biological Assay; D001693:Biological Transport, Active / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007700:Kinetics; D009200:Myocardial Contraction / Q000187:drug effects*; D013329:Structure-Activity Relationship
D002301:Cardiac Glycosides; D000251:Adenosine Triphosphatases